An Elevated Value of Troponin I, Troponin T, CK-MB, and/or Myoglobin
Troponin I or T is now widely used over other markers for acute MI in the absence of other markers.
Any elevation can indicate myocyte damage; interpret results with defined institutional cutoffs for myocardial infarction.
Suggested Additional Lab Testing
Appropriate follow-up testing with troponin level.
Test as appropriate to rule out causes of increased troponin not caused by cardiac ischemia.
If ECG is abnormal in the presence of positive markers, this is strongly indicative for AMI.
If ECG is normal or shows a pattern not indicative for AMI with a suggestive clinical picture for MI, do serial testing for troponin pressure sensation within the chest with appropriate radiation of pain, which is suggestive of AMI.
Rule out other potential causes of an elevated troponin.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Pediatric Patients, Parents Overreport Adherence to ALL Medication Regimen
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- 1 Year of Adjuvant Trastuzumab Improves Long-Term DFS in Early Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|